Title | Type | SJR | H index | Total Docs. (2012) | Total Docs. (3years) | Total Refs. (2012) | Total Cites (3years) | Citable Docs. (3years) | Cites / Doc. (2years) | Ref. / Doc. (2012) | %Female (2012) | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
101 | Investigational New Drugs | journal | 1.100 Q2 | 97 | 273 | 356 | 8820 | 1139 | 354 | 3.30 | 32.31 | 37.54 | |
102 | Molecular Imaging and Biology | journal | 1.100 Q2 | 78 | 88 | 292 | 2986 | 961 | 280 | 3.34 | 33.93 | 31.17 | |
103 | Journal of Carcinogenesis | journal | 1.086 Q2 | 43 | 21 | 65 | 1228 | 196 | 61 | 2.44 | 58.48 | 35.62 | |
104 | Recent Patents on Anti-Cancer Drug Discovery | journal | 1.082 Q2 | 52 | 24 | 80 | 3030 | 254 | 77 | 2.98 | 126.25 | 41.41 | |
105 | Cancer Chemotherapy and Pharmacology | journal | 1.081 Q2 | 122 | 285 | 899 | 8681 | 2878 | 877 | 3.18 | 30.46 | 34.37 | |
106 | Therapeutic Advances in Medical Oncology | journal | 1.051 Q2 | 68 | 30 | 76 | 1435 | 187 | 66 | 2.90 | 47.83 | 43.75 | |
107 | Current Treatment Options in Oncology | journal | 1.039 Q2 | 66 | 41 | 73 | 2300 | 261 | 71 | 3.23 | 56.10 | 39.81 | |
108 | Cancer Nursing | journal | 1.006 Q2 | 86 | 95 | 248 | 3834 | 525 | 225 | 2.04 | 40.36 | 74.04 | |
109 | Leukemia and Lymphoma | journal | 0.999 Q2 | 102 | 465 | 1182 | 13167 | 2040 | 818 | 1.69 | 28.32 | 39.75 | |
110 | Head and Neck Oncology (discontinued) | journal | 0.998 Q2 | 44 | 88 | 134 | 2227 | 464 | 133 | 3.08 | 25.31 | 28.61 | |
111 | Cancer Epidemiology | journal | 0.995 Q2 | 86 | 158 | 338 | 5424 | 885 | 324 | 2.39 | 34.33 | 43.53 | |
112 | Familial Cancer | journal | 0.972 Q2 | 67 | 88 | 266 | 2791 | 593 | 261 | 2.18 | 31.72 | 54.98 | |
113 | Cellular oncology (Dordrecht) | journal | 0.954 Q2 | 58 | 45 | 52 | 2027 | 112 | 51 | 2.15 | 45.04 | 41.56 | |
114 | Oncology Reports | journal | 0.949 Q2 | 115 | 605 | 1273 | 20706 | 3448 | 1273 | 2.70 | 34.22 | 34.39 | |
115 | Breast | journal | 0.942 | 98 | 149 | 383 | 4334 | 837 | 349 | 2.04 | 29.09 | 44.72 | |
116 | Cancer Cell International | journal | 0.938 Q2 | 80 | 53 | 118 | 2058 | 342 | 117 | 2.57 | 38.83 | 41.24 | |
117 | Anti-Cancer Drugs | journal | 0.936 Q2 | 102 | 136 | 391 | 5235 | 1230 | 383 | 2.81 | 38.49 | 42.08 | |
118 | American Journal of Clinical Oncology: Cancer Clinical Trials | journal | 0.935 Q2 | 90 | 105 | 351 | 3181 | 814 | 334 | 2.47 | 30.30 | 33.69 | |
119 | Japanese Journal of Clinical Oncology | journal | 0.924 Q2 | 95 | 207 | 627 | 4602 | 1453 | 567 | 2.06 | 22.23 | 15.77 | |
120 | Sarcoma | journal | 0.893 Q2 | 53 | 68 | 105 | 3613 | 289 | 104 | 2.86 | 53.13 | 32.01 | |
121 | Journal of Oncology Practice | journal | 0.887 Q2 | 0 | 0 | 0 | 0 | 0 | 0 | 0.00 | 0.00 | 0.00 | |
122 | Leukemia Research | journal | 0.885 Q2 | 96 | 361 | 1486 | 9435 | 2501 | 989 | 1.93 | 26.14 | 43.68 | |
123 | International Journal of Gynecological Cancer | journal | 0.882 Q2 | 101 | 279 | 888 | 6315 | 2135 | 829 | 2.15 | 22.63 | 39.17 | |
124 | Expert Review of Anticancer Therapy | journal | 0.875 Q2 | 85 | 157 | 564 | 9329 | 1383 | 494 | 2.24 | 59.42 | 31.36 | |
125 | Journal of Cancer | journal | 0.873 Q2 | 81 | 53 | 96 | 2011 | 242 | 94 | 2.52 | 37.94 | 33.33 | |
126 | Journal of Supportive Oncology | journal | 0.872 Q2 | 65 | 42 | 150 | 1486 | 278 | 111 | 1.76 | 35.38 | 54.01 | |
127 | Urologic Oncology: Seminars and Original Investigations | journal | 0.868 Q2 | 85 | 199 | 528 | 4618 | 1024 | 467 | 2.29 | 23.21 | 23.90 | |
128 | Journal of Ovarian Research | journal | 0.866 Q2 | 61 | 45 | 69 | 1984 | 208 | 69 | 2.71 | 44.09 | 45.34 | |
129 | Clinical Colorectal Cancer | journal | 0.864 Q2 | 63 | 44 | 151 | 1581 | 308 | 135 | 1.80 | 35.93 | 33.33 | |
130 | Biologics: Targets and Therapy | journal | 0.845 Q2 | 47 | 46 | 67 | 3347 | 202 | 66 | 3.11 | 72.76 | 44.37 | |
131 | Clinical Lymphoma, Myeloma and Leukemia | journal | 0.839 Q2 | 65 | 75 | 350 | 2424 | 636 | 334 | 1.81 | 32.32 | 39.87 | |
132 | Infectious Agents and Cancer | journal | 0.836 Q2 | 47 | 34 | 93 | 1620 | 242 | 93 | 2.30 | 47.65 | 48.94 | |
133 | Surgical Oncology | journal | 0.813 Q2 | 75 | 68 | 167 | 3667 | 443 | 152 | 2.56 | 53.93 | 27.76 | |
134 | OncoTargets and Therapy | journal | 0.805 Q2 | 86 | 51 | 64 | 2641 | 152 | 64 | 3.12 | 51.78 | 37.08 | |
135 | European Journal of Cancer Prevention | journal | 0.799 Q2 | 88 | 84 | 229 | 3604 | 732 | 224 | 3.17 | 42.90 | 39.68 | |
136 | Current Hematologic Malignancy Reports | journal | 0.796 Q2 | 44 | 41 | 97 | 2338 | 217 | 96 | 2.31 | 57.02 | 34.62 | |
137 | Breast Cancer: Basic and Clinical Research | journal | 0.795 Q2 | 35 | 16 | 46 | 694 | 111 | 44 | 2.40 | 43.38 | 44.44 | |
138 | Anticancer Research | journal | 0.788 Q2 | 136 | 733 | 2116 | 24307 | 4706 | 2109 | 2.04 | 33.16 | 30.24 | |
139 | Journal of Gynecologic Oncology | journal | 0.787 Q2 | 52 | 74 | 168 | 1500 | 319 | 144 | 1.75 | 20.27 | 32.73 | |
140 | Current Opinion in Supportive and Palliative Care | journal | 0.783 Q2 | 50 | 79 | 161 | 3141 | 394 | 152 | 2.07 | 39.76 | 47.20 | |
141 | Cancer Management and Research | journal | 0.770 Q2 | 67 | 47 | 63 | 2398 | 161 | 63 | 2.56 | 51.02 | 41.62 | |
142 | Immunotherapy | journal | 0.762 Q2 | 65 | 152 | 375 | 7690 | 711 | 299 | 1.98 | 50.59 | 33.33 | |
143 | Neoplasma | journal | 0.762 | 57 | 95 | 246 | 2716 | 497 | 246 | 1.93 | 28.59 | 39.04 | |
144 | Cancer Biotherapy and Radiopharmaceuticals | journal | 0.756 Q2 | 68 | 93 | 267 | 3431 | 591 | 256 | 2.01 | 36.89 | 40.32 | |
145 | Current Oncology | journal | 0.755 Q2 | 68 | 134 | 281 | 3788 | 451 | 232 | 1.55 | 28.27 | 39.33 | |
146 | Pathology and Oncology Research | journal | 0.743 Q2 | 61 | 143 | 319 | 4994 | 644 | 318 | 1.83 | 34.92 | 40.17 | |
147 | Chemotherapy | journal | 0.735 Q2 | 61 | 61 | 186 | 2084 | 446 | 181 | 2.51 | 34.16 | 30.75 | |
148 | Breast Journal | journal | 0.727 Q2 | 81 | 164 | 490 | 2409 | 769 | 343 | 1.48 | 14.69 | 47.74 | |
149 | Integrative Cancer Therapies | journal | 0.716 Q2 | 71 | 37 | 138 | 1761 | 386 | 120 | 2.33 | 47.59 | 43.89 | |
150 | Cancer Research and Treatment | journal | 0.706 Q2 | 58 | 42 | 40 | 955 | 102 | 40 | 2.55 | 22.74 | 37.61 |
Follow us on @ScimagoJR
Scimago Lab, Copyright 2007-2024. Data Source: Scopus®